SEC Form 4 · accession 0001479791-17-000005
INVO Bioscience, Inc. · IVOB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Claude Ranoux
10% Owner
Period of report
Aug 8, 2017
Accepted (ET)
Dec 28, 2017 · 2:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001417926
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| INVO Bioscience Common Stock | Aug 8, 2017 | I | 500,000 | $0.0001 | D | 26,473,122 | D | |
| INVO Bioscience Common Stock | Aug 8, 2017 | S | 50,000 | $0.30 | D | 26,423,122 | D | |
| INVO Bioscience Common Stock | Aug 8, 2017 | S | 140,000 | $0.05 | D | 26,283,122 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
The 500,000 shares were disposed to spouse pursuant to a divorce decree. These forms were initially filed on August 8, 2017 and inadvertently reported on incorrect forms Schedule 13D.